Memantine Hydrochloride

Memantine Hydrochloride
Product Description

CAS: 41100-52-1USP and In-house specifications

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and anti-allergic products.

Olpha JSC

  • Country/Region:
    Latvia
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Generic APIs producer
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • CAS Registry Number
    41100-52-1
  • Supplied from
    Latvia

Olpha JSC

  • Country/Region:
    Latvia
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Generic APIs producer
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from Olpha JSC (2)

  • Amantadine Hydrochloride

    Product Amantadine Hydrochloride

    CAS: 665-66-7USP and CEP specifications

    The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, a...
  • Vildagliptin

    Product Vildagliptin

    CAS: 274901-16-5
    The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial...

Olpha JSC resources (2)

  • News About Olpha

    Olpha is one of the leading pharmaceutical manufacturers in chemical and pharmaceutical sector of the Baltic countries with 50 years of experience. Olpha exports solid FDFs, APIs and intermediates to more than 60 countries worldwide.

    Olpha has a long-term strategy to expand portfolio and develop sustainable business in European countries and MENA region. Olpha develops, manufactures and distributes FDF products for treatment in Oncology, Neurology, Cardiology and Anti-diabetes therapeutical areas.
  • Video Olpha | Quality healthcare within reach

    Olpha is your knowledgeable companion in the maze of accessible healthcare. We believe that better health is achievable, and with Olpha it is closer than you think!